Mojirade James's most recent trade in Avanos Medical Inc was a trade of 16,300 Common Stock done . Disclosure was reported to the exchange on April 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 16,300 | 104,518 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 41,199 | 41,199 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 19,201 | 88,218 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 2,785 | 69,017 (0%) | 0% | 15.3 | 42,611 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 1,846 | 71,802 (0%) | 0% | 15.3 | 28,244 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 8,039 | 78,352 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 2,636 | 75,716 (0%) | 0% | 15.1 | 39,883 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 2,068 | 73,648 (0%) | 0% | 15.1 | 31,289 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.99 per share. | 22 Jul 2024 | 684 | 70,313 (0%) | 0% | 22.0 | 15,041 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 19.14 per share. | 06 Mar 2024 | 30,695 | 72,948 (0%) | 0% | 19.1 | 587,502 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.00 per share. | 06 Mar 2024 | 1,951 | 70,997 (0%) | 0% | 19 | 37,069 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.76 per share. | 05 Mar 2024 | 2,190 | 42,253 (0%) | 0% | 18.8 | 41,084 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.15 per share. | 20 Jul 2023 | 663 | 44,443 (0%) | 0% | 26.1 | 17,337 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 20,339 | 47,217 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.62 per share. | 06 Mar 2023 | 2,111 | 45,106 (0%) | 0% | 29.6 | 62,528 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.41 per share. | 20 Jul 2022 | 663 | 26,878 (0%) | 0% | 27.4 | 18,173 | Common Stock |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 20,233 | 27,541 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Mojirade James | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 34.21 per share. | 20 Jul 2021 | 7,308 | 7,308 (0%) | 0% | 34.2 | 250,007 | Common Stock |